MicroRNAs as potential biomarkers in malignant pleural mesothelioma

Current Biomarker Findings ◽

10.2147/cbf.s72199 ◽

2015 ◽

pp. 1

Author(s):

Eric Santoni-Rugiu ◽

Morten Andersen ◽

Morten Grauslund

Keyword(s):

Malignant Pleural Mesothelioma ◽

Pleural Mesothelioma ◽

Potential Biomarkers

Download Full-text

CD44 and its ligand hyaluronan as potential biomarkers in malignant pleural mesothelioma: evidence and perspectives

Respiratory Research ◽

10.1186/s12931-017-0546-5 ◽

2017 ◽

Vol 18 (1) ◽

Cited By ~ 16

Author(s):

Lourdes Cortes-Dericks ◽

Ralph Alexander Schmid

Keyword(s):

Malignant Pleural Mesothelioma ◽

Pleural Mesothelioma ◽

Potential Biomarkers

Download Full-text

1769d Combination of mirnas, mesothelin and fibulin-3 as potential biomarkers in malignant pleural mesothelioma and asbestos-exposed subjects

10.1136/oemed-2018-icohabstracts.438 ◽

2018 ◽

Author(s):

AC Pesatori ◽

L Angelici ◽

C Favero ◽

L Dioni ◽

C Mensi ◽

...

Keyword(s):

Malignant Pleural Mesothelioma ◽

Pleural Mesothelioma ◽

Potential Biomarkers

Download Full-text

A New Prognostic Score for Treatment Allocation for Multimodality Therapy for Malignant Pleural Mesothelioma – An Update

Zentralblatt für Chirurgie - Zeitschrift für Allgemeine Viszeral- Thorax- und Gefäßchirurgie ◽

10.1055/s-0036-1587540 ◽

2016 ◽

Vol 141 (S 01) ◽

Author(s):

I Opitz ◽

M Friess ◽

O Lauk ◽

T Frauenfelder ◽

TDL Ngyuyen ◽

...

Keyword(s):

Malignant Pleural Mesothelioma ◽

Prognostic Score ◽

Multimodality Therapy ◽

Pleural Mesothelioma ◽

Treatment Allocation

Download Full-text

Influence of Methallothionein Expression on Sensitivity Against Platin Compounds in Human Malignant Pleural Mesothelioma Cell Lines – Knock-Down of Gene Expression as New Therapeutic Approach?

10.1055/s-0039-1678402 ◽

2019 ◽

Author(s):

Sabrina Borchert ◽

Pia Suckrau ◽

Michael Wessolly ◽

Jan Schmeller ◽

Elena Mairinger ◽

...

Keyword(s):

Gene Expression ◽

Cell Lines ◽

Malignant Pleural Mesothelioma ◽

Therapeutic Approach ◽

Pleural Mesothelioma ◽

Knock Down ◽

Malignant Pleural Mesothelioma Cell ◽

Mesothelioma Cell

Download Full-text

Poor nutritional status negatively influences prognosis of malignant pleural mesothelioma patients undergoing multimodal therapy

10.1055/s-0039-1694114 ◽

2019 ◽

Author(s):

O Lauk ◽

M Hashimoto ◽

U Held ◽

M Friess ◽

W Weder ◽

...

Keyword(s):

Nutritional Status ◽

Malignant Pleural Mesothelioma ◽

Multimodal Therapy ◽

Pleural Mesothelioma ◽

Poor Nutritional Status

Download Full-text

Prognostic significance of nuclear grade in malignant pleural mesothelioma: A single institution experience

10.26226/morressier.578f37fdd462b8028d8902e7 ◽

2016 ◽

Author(s):

Simge Erbil

Keyword(s):

Malignant Pleural Mesothelioma ◽

Prognostic Significance ◽

Nuclear Grade ◽

Pleural Mesothelioma ◽

Single Institution

Download Full-text

Neoadjuvant Immune Checkpoint Blockade in Resectable Malignant Pleural Mesothelioma

Case Medical Research ◽

10.31525/ct1-nct03918252 ◽

2019 ◽

Author(s):

Keyword(s):

Malignant Pleural Mesothelioma ◽

Immune Checkpoint ◽

Immune Checkpoint Blockade ◽

Checkpoint Blockade ◽

Pleural Mesothelioma

Download Full-text

A Study of Pembrolizumab in Combination With Cisplatin and Pemetrexed in Advanced Malignant Pleural Mesothelioma (MPM) (MK-3475-A17)

Case Medical Research ◽

10.31525/ct1-nct04153565 ◽

2019 ◽

Author(s):

Keyword(s):

Malignant Pleural Mesothelioma ◽

Pleural Mesothelioma

Download Full-text

Faculty Opinions recommendation of Pleurectomy/decortication is superior to extrapleural pneumonectomy in the multimodality management of patients with malignant pleural mesothelioma.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.715898021.791402848 ◽

2012 ◽

Author(s):

Paul Van Schil

Keyword(s):

Malignant Pleural Mesothelioma ◽

Extrapleural Pneumonectomy ◽

Pleural Mesothelioma

Download Full-text

Faculty Opinions recommendation of Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725915176.793512682 ◽

2015 ◽

Author(s):

Paul Van Schil

Keyword(s):

Neoadjuvant Chemotherapy ◽

Malignant Pleural Mesothelioma ◽

Extrapleural Pneumonectomy ◽

Pleural Mesothelioma ◽

Phase 2 ◽

Multicentre Phase ◽

Phase 2 Trial

Download Full-text